Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI)
Karen A. Burek, RN, MS*,
Kim Sutton-Tyrrell, DrPH1, ,
Maria Mori Brooks, PhD ,
Barbara Naydeck, MPH ,
Norma Keller, MD ,
Mary Ann Sellers, RN, MSN ,
Gary Roubin, MD, FACC||,
R. ena Jandová, MD, CSc¶ and
Charanjit S. Rihal, MD, FACC#
* University of Michigan Health System, Ann Arbor, Michigan, USA
University of Pittsburgh, Pittsburgh, Pennsylvania, USA
New York University Medical Center, New York, New York, USA
Duke University Medical Center, Durham, North Carolina, USA
|| University of Alabama, Birmingham, Alabama, USA
¶ Institute of Clinical and Experimental Medicine, Prague, Czech Republic
# Mayo Clinic, Rochester, Minnesota, USA

View larger version (13K):
[in a new window]
|
Figure 1 Distribution of the ankle/arm index measures in the LEAD substudy of BARI.
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Kaplan-Meier survival curves for patients with and without LEAD in the LEAD substudy of BARI.
|
|
|